2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$60.22+$0.20 (+0.32%)
Price as of Jul 31, 2026 7:38 PM EDT- $11.6BMarket Cap
- 3.23%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$60.22+$0.20 (+0.32%)
Earnings Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 8.48% | ||
12-Month Momentum | -0.05% | ||
3-Month Risk Adjusted Momentum | 49.10% | ||
12-Month Risk Adjusted Momentum | -0.15% |
True Yield
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.13% | ||
Net Debt Paydown Yield | -7.58% |
Financial Health Score
Valuation | BMRN | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 8 |